Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    "New daily-persistent headache"
Show Display Options
Rank Status Study
1 Terminated OnabotulinumtoxinA for the Treatment of New Daily Persistent Headache: an Open Label Study
Condition: New Daily Persistent Headache
Intervention: Drug: OnabotulinumtoxinA
2 Completed A Research Study To Compare Two Kinds Of Daily Headache
Condition: Migraine
Intervention:

Study has passed its completion date and status has not been verified in more than two years.